121 related articles for article (PubMed ID: 29496374)
1. Sustained response to lenalidomide for early relapsed marginal zone lymphoma.
Ibrahimi S; Vidal G; Mukherjee S; Alhyari L; Scordino T; Cherry M
Blood Cells Mol Dis; 2018 Jul; 71():53-54. PubMed ID: 29496374
[No Abstract] [Full Text] [Related]
2. Prolonged follow-up on lenalidomide-based treatment for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)-Real-world data from the Medical University of Vienna.
Kiesewetter B; Lamm W; Neuper O; Mayerhoefer ME; Simonitsch-Klupp I; Raderer M
Hematol Oncol; 2019 Oct; 37(4):345-351. PubMed ID: 31283840
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of cereblon and MUM1 as potential predictive markers of response to lenalidomide in extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma).
Kiesewetter B; Simonitsch-Klupp I; Kornauth C; Dolak W; Lukas J; Mayerhoefer ME; Raderer M
Hematol Oncol; 2018 Feb; 36(1):62-67. PubMed ID: 28833354
[TBL] [Abstract][Full Text] [Related]
4. IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma.
Pirosa MC; Sassone M; Kiesewetter B; Guillermo AL; Devizzi L; Domènech ED; Tucci A; Mannina D; Merli M; Salar A; Visco C; Esposito F; Bonomini L; Zucca E; Ferreri AJM; Raderer M
Haematologica; 2023 Jun; 108(6):1671-1675. PubMed ID: 36546422
[No Abstract] [Full Text] [Related]
5. The AUGMENT study: Lenalidomide in indolent lymphoma … balance the imbalance!
Dada R
Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):46-47. PubMed ID: 31676307
[TBL] [Abstract][Full Text] [Related]
6. Lenalidomide induced reversible parkinsonism, dystonia, and dementia in subclinical Creutzfeldt-Jakob disease.
Argente-Escrig H; Martinez JC; Gómez E; Balaguer A; Sevilla T; Bataller L
J Neurol Sci; 2018 Oct; 393():140-141. PubMed ID: 30193135
[No Abstract] [Full Text] [Related]
7. Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
Broccoli A; Pellegrini C; Celli M; Argnani L; Agostinelli C; Pileri S; Zinzani PL
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e119-22. PubMed ID: 24629851
[No Abstract] [Full Text] [Related]
8. Extranodal marginal zone lymphoma of MALT involving the lungs, the stomach, and the colon.
Fares MD; Abbas OM; Jamaleddine GW
Lung Cancer; 2006 Dec; 54(3):427-9. PubMed ID: 16959369
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal cryoglobulinemia: the first manifestation of gastric marginal B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma).
Gimeno E; Sorlí L; Serrano S; Besses C; Salar A
Leuk Res; 2006 Nov; 30(11):1465-6. PubMed ID: 16481038
[No Abstract] [Full Text] [Related]
10. Nodal relapse after Helicobacter pylori eradication in a patient with primary localized gastric mucosa-associated lymphoid tissue lymphoma.
Kato H; Kagami Y; Kodaira T; Oka S; Oki Y; Chihara D; Taji H; Yatabe Y; Nakamura T; Nakamura S; Seto M; Yamamoto K; Morishima Y
Am J Gastroenterol; 2011 Mar; 106(3):549-51. PubMed ID: 21378774
[No Abstract] [Full Text] [Related]
11. Preserved lenalidomide efficacy in a recurrent isolated subcutaneous mantle cell lymphoma relapse.
Bagacean C; Neaga A; Zdrenghea M; Tempescul A
J BUON; 2018; 23(1):273-274. PubMed ID: 29552797
[No Abstract] [Full Text] [Related]
12. Single-agent lenalidomide is active in patients with relapsed or refractory aggressive non-Hodgkin lymphoma who received prior stem cell transplantation.
Vose JM; Habermann TM; Czuczman MS; Zinzani PL; Reeder CB; Tuscano JM; Lossos IS; Li J; Pietronigro D; Witzig TE
Br J Haematol; 2013 Sep; 162(5):639-47. PubMed ID: 23834234
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous marginal zone lymphoma (immunocytoma like) with lymphoepithelioid or Lennert's lymphoma like involvement of nodes.
Shet T; Basak R; Epari S
Indian J Pathol Microbiol; 2012; 55(2):222-6. PubMed ID: 22771649
[TBL] [Abstract][Full Text] [Related]
14. Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002.
Ishida T; Fujiwara H; Nosaka K; Taira N; Abe Y; Imaizumi Y; Moriuchi Y; Jo T; Ishizawa K; Tobinai K; Tsukasaki K; Ito S; Yoshimitsu M; Otsuka M; Ogura M; Midorikawa S; Ruiz W; Ohtsu T
J Clin Oncol; 2016 Dec; 34(34):4086-4093. PubMed ID: 27621400
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial.
Oh SY; Kim WS; Kim JS; Chae YS; Lee GW; Eom HS; Ryoo HM; Lee S; Kim SJ; Yoon DH; Won JH; Hong J; Park J; Lee SM; Hong JY; Park E; Kim HJ; Yang DH; Kim HJ; Suh C
Leuk Lymphoma; 2016; 57(6):1406-12. PubMed ID: 26413982
[TBL] [Abstract][Full Text] [Related]
16. A 77-Year-Old Man with Multiple Myeloma and a Lytic Bone Lesion.
Sassine J; Kontoyiannis DP
Am J Med; 2021 Jul; 134(7):860-862. PubMed ID: 33621531
[No Abstract] [Full Text] [Related]
17. Nodal marginal zone lymphoma with increased large cells: myth versus entity.
Kaur P
Arch Pathol Lab Med; 2011 Aug; 135(8):964-6. PubMed ID: 21809985
[No Abstract] [Full Text] [Related]
18. [The primary pulmonary Malt lymphoma: About a case].
Moustarhfir Elidrissi A; Benjelloun H; Zaghba N; Yassine N
Rev Pneumol Clin; 2017 Jun; 73(3):156-157. PubMed ID: 28365048
[No Abstract] [Full Text] [Related]
19. The pleural sandwich sign in two cases of primary pleural lymphoma.
Kim Y; Lee M; Ryu YJ; Cho MS
Korean J Radiol; 2015; 16(1):213-6. PubMed ID: 25598693
[TBL] [Abstract][Full Text] [Related]
20. Marginal zone B-cell lymphoma of the head and neck: a rare case and review.
McLellan M; Hasserjian R; Emerick K
Laryngoscope; 2010; 120 Suppl 4():S165. PubMed ID: 21225763
[No Abstract] [Full Text] [Related]
[Next] [New Search]
